Abstract
This study investigated the receptor binding affinities of a C5a agonist and cyclic antagonists for polymorphonuclear leukocytes (PMNs) isolated from human, sheep, pig, dog, rabbit, guinea pig, rat and mouse. The affinities of the two small molecule antagonists, F-[OPdChaWR] and AcF-[OPdChaWR], and the agonist, YSFKPMPLaR, revealed large differences in C5a receptor (C5aR) affinities between species. The antagonists bound to human, rat and dog PMNs with similar high affinities, but with lower affinities to PMNs from all other species. The C5a agonist also bound with varying affinities between species, but showed a different affinity profile to the antagonists. In contrast, recombinant human C5a had similar affinity for PMNs of all species investigated. The low correlation between the affinities of the antagonists and the agonist between species either suggests that different receptor residues are important for distinguishing between agonist/antagonist binding, or that the agonist and antagonist peptides bind to two distinct sites within the C5aR.
Similar content being viewed by others
References
Hugli, T. E. 1981. The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a. Crit. Rev. Immunol. 1:321–366.
Stimler, N. P., W. E. Brocklehurst, C. M. Bloor, and T. E. Hugli. 1981. Anaphylatoxin-mediated contraction of guinea pig lung strips: a nonhistamine tissue response. J. Immunol. 126:2258–2261.
Marceau, F., C. Lundberg, and T. E. Hugli. 1987. Effects of the anaphylatoxins on circulation. Immunopharmacology 14:67–84.
Kohl, J., and D. Bitter-Suermann. 1993. Anaphylatoxins. In: Complement in Health & Disease (Whaley K., Loos, M., and Weiler, J., eds.), Kluwer Academic, Victoria, Australia. 299–324.
Tempero, R. M., M. A. Hollingsworth, M. D. Burdick, A. M. Finch, S. M. Taylor, S. M. Vogen, E. L. Morgan, and S. R. A. Sanderson. 1997. Molecular adjuvant effects of a conformationally biased agonist of human C5a anaphylatoxin. J. Immunol. 158:1377–1382.
Gerard, N. P., and C. Gerard. 1991. The chemotactic receptor for human C5a anaphylatoxin. Nature 349:614–617.
Gerard, C., L. Bao, O. Orozco, M. Pearson, D. Kunz, and N. P. Gerard. 1992. Structural diversity in the extracellular faces of peptidergic G-protein-coupled receptors. Molecular cloning of the mouse C5a anaphylatoxin receptor. J. Immunol. 149:2600–2606.
Perret, J. J., E. Raspe, G. Vassart, and M. Parmentier. 1992. Cloning and functional expression of the canine anaphylatoxin C5a receptor. Evidence for high interspecies variability. Biochem. J. 288:911–917.
Alvarez, V., E. Coto, F. Setien, S. Gonzalez-Roces, and C. Lopez-Larrea. 1996. Molecular evolution of the N-formyl peptide and C5a receptors in non-human primates. Immunogenetics 44:446–452.
Akatsu, H., T. Miwa, C. Sakurada, Y. Fukuoka, J. A. Ember, T. Yamamoto, T. E. Hugli, and H. Okada. 1997. cDNA cloning and characterization of rat C5a anaphylatoxin receptor. Microbiol. Immunol. 41:575–580.
Fukuoka, Y., J. A. Ember, A. Yasui, and T. E. Hugli. 1998. Cloning and characterization of the guinea pig C5a anaphylatoxin receptor: interspecies diversity among the C5a receptors: Int. Immunol. 10:275–283.
Bachvarov, D. R., S. Houle, M. Bachvarova, J. Bouthillier, S. A. St.-Pierre, Y. Fukuoka, J. A. Ember, and F. Marceau. 1999. Cloning and preliminary pharmacological characterization of the anaphylatoxin C5a receptor in the rabbit. Br. J. Pharmacol. 128:321–326.
Gerard, C., and N. P. Gerard. 1994. C5a anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12:775–808.
Jose, P. J., I. K. Moss, R. N. Maini, and T. J. Williams. 1990. Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase. Ann. Rheum. Dis. 49:747–752.
Wang, Y., S. A. Rollins, J. A. Madri, and L. A. Matis. 1995. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc. Natl. Acad. Sci. U.S.A. 92:8955–8959.
Gasque, P., S. K. Singhrao, J. W. Neal, O. Gotze, and B. P. Morgan. 1997. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am. J. Pathol. 150:31–41.
Smedegard, G., L. X. Cui, and T. E. Hugli. 1989. Endotoxininduced shock in the rat. A role for C5a. Am. J. Pathol. 135:489–497. Receptor Affinities of C5a Analogues 177
Short, A., A. K. Wong, A. M. Finch, G. Haaima, I. A. Shiels, D. P. Fairlie, and S. M. Taylor. 1999. Effects of a new C5a receptor antagonist on C5a-and endotoxin-induced neutropenia in the rat. Br. J. Pharmacol. 126:551–554.
Stevens, J. H., P. O'Hanley, J. M. Shapiro, F. G. Mihm, P. S. Satoh, J. A. Collins, and T. A. Raffin. 1986. Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J. Clin. Invest. 77:1812–1816.
Finch, A. M., A. K. Wong, N. J. Paczkowski, S. K. Wadi, D. J. Craik, D. P. Fairlie, and S. M. Taylor. 1999. Low-molecularweight peptidic and cyclic antagonists of the receptor for the complement factor C5a. J. Med. Chem. 42:1965–1974.
Paczkowski, N. J., A. M. Finch, J. B. Whitmore, A. J. Short, A. K. Wong, P. N. Monk, S. A. Cain, D. P. Fairlie, and S. M. Taylor. 1999. Pharmacological characterization of antagonists of the C5a receptor. Br. J. Pharmacol. 128:1461–1466.
Finch, A. M., S. M. Vogen, S. A. Sherman, L. Kirnarsky, S. M. Taylor, and S. D. Sanderson. 1997. Biologically active conformer of the effector region of human C5a and modulatory effects of Nterminal receptor binding determinants on activity. J. Med. Chem. 40:877–884.
Wong, A. K., A. M. Finch, G. K. Pierens, D. J. Craik, S. M. Taylor, and D. P. Fairlie. 1998. Small molecular probes for G-proteincoupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a. J. Med. Chem. 41:3417–3425.
Sanderson, S. D., L. Kirnarsky, S. A. Sherman, J. A. Ember, A. M. Finch, and S. M. Taylor. 1994. Decapeptide agonists of human C5a: the relationship between conformation and spasmogenic and platelet aggregatory activities. J. Med. Chem. 37:3171–3180.
Strachan, A. J., T. M. Woodruff, G. Haaima, D. P. Fairlie, and S. M. Taylor. 2000. A New Small Molecule C5a Receptor Antagonist Inhibits the Reverse-Passive Arthus Reaction and Endotoxic Shock in Rats. J. Immunol. 164:6560–6565.
Siciliano, S. J., T. E. Rollins, J. DeMartino, Z. Konteatis, L. Malkowitz, R. G. Van, S. Bondy, H. Rosen, and M. S. Springer. 1994. Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors. Proc. Natl. Acad. Sci. U.S.A. 91:1214–1218.
DeMartino, J. A., R. G. Van, S. J. Siciliano, C. J. Molineaux, Z. D. Konteatis, H. Rosen, and M. S. Springer. 1994. The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a Analogs. J. Biol. Chem. 269:14446–14450.
Mery, L., and F. Boulay. 1994. The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding. J. Biol. Chem. 269:3457–3463.
Monk, P. N., M. D. Barker, L. J. Partridge, and J. E. Pease. 1995. Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus. J. Biol. Chem. 270:16625–16629.
DeMartino, J. A., Z. D. Konteatis, S. J. Siciliano, R. G. Van, D. J. Underwood, P. A. Fischer, and M. S. Springer. 1995. Arginine 206 of the C5a receptor is critical for ligand recognition and receptor activation by C-terminal hexapeptide analogs. J. Biol. Chem. 270:15966–15969.
Raffetseder, U., D. Roper, L. Mery, C. Gietz, A. Klos, J. Grotzinger, A. Wollmer, F. Boulay, J. Kohl, and W. Bautsch. 1996. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg206 determines highaffinity binding sites of C5a receptor. Eur. J. Biochem. 235:82–90.
Kawatsu, R., S. D. Sanderson, I. Blanco, N. Kendall, A. M. Finch, S. M. Taylor, and D. Colcher. 1996. Conformationally biased analogs of human C5a mediate changes in vascular permeability. J. Pharmacol. Exp. Ther. 278:432–440.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Woodruff, T.M., Strachan, A.J., Sanderson, S.D. et al. Species Dependence for Binding of Small Molecule Agonist and Antagonists to the C5a Receptor on Polymorphonuclear Leukocytes. Inflammation 25, 171–177 (2001). https://doi.org/10.1023/A:1011036414353
Issue Date:
DOI: https://doi.org/10.1023/A:1011036414353